Replies to post #2009 on pumpers paradise

[roger wilco]

ZigZag! Good morning! Hey radar EWPI +.005! news this AM!

Emerging World Pharma Inc. Strategic Partner African Global Pharma GH in Negotiations to Finalize Agreement for Sale and Dist...


Emerging World Pharma Inc. (PINKSHEETS: EWPI) -- Emerging World Pharma Inc. strategic partner African Global Pharma Corp. (AGP) is negotiating an agreement to distribute our full line of pharmaceutical products to several West African countries. Ghana acts as the gateway to a huge sub-regional market of over 250 million people. This is the first endeavour for AGP to broaden our market base outside of Ghana. The current line of medicines being produced in AGP's Ghana manufacturing facility are Glaten® (anti-hypertensive), Glibenclamide (anti-diabetic), Globartem®, Gloderp (anti-malarials) and Paracetamol (pain relieving analgesic). "We are proud to announce this collaboration. Together with African Global Pharma GH, our company will continue to expand the distribution of our product line in the West African market. We see great commercial potential in the product line going forward. We endeavor to ensure the availability of world class, quality medicines within reach at affordable prices," stated Emerging World Pharma President Steve Ignatavicius.

About African Global Pharma, Ghana

African Global Pharma (Ghana) Limited is an affiliated company of African GlobalPharma Corp. of Canada with business partnership with the Catholic Diocese of Sunyani to distribute all our manufactured drugs to the Catholic Mission Hospitals. African Global Pharma's production facility in Sunyani, Ghana was fully rehabilitated and built by African Global Pharma Corp., Canada. The plant and its operations are headquartered in Sunyani at the Diocesan Bldg.

For more on AGP click here http://www.globalpharmacorp.ca/african-gp-ghana.html

About Emerging World Pharma Inc.

Emerging World Pharma Inc. is an investor in generic based pharmaceutical companies manufacturing within developing nations. The company focuses its investments on generic pharmaceutical companies that have contracts with three major buyer groups; church, government and wholesalers. Market research shows that these branches are the most secure, protected and reputable for the distribution of medicines.

For more on Emerging World Pharma Inc. click here http://www.emergingpharma.com/